PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin...

por Buonaiuto, Giulia, De Mori, Valentina, Braus, Alessandra, Balini, Annalisa, Berzi, Denise, Carpinteri, Rita, Forloni, Franco, Meregalli, Giancarla, Ronco, Gian Luca, Bossi, Antonio C
Publicado 2016